|
|
Article: Stakeholder Opinions: Bone Metastases Presents Current Treatment Options and Identification of Unmet Needs in Bone Metastases.
- Article from:
- Business Wire
- Article date:
- April 25, 2008
CopyrightCOPYRIGHT 2008 Business Wire. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c89960) has announced the addition of "Stakeholder Opinions: Bone Metastases - Impending Patent Expiries May Help Make or Break Newer Agents" to their offering.
Bone metastases are a complication of some advanced cancers including cancers of the breast, lung, prostate, kidney and thyroid. The incidence of bone metastases across these tumour types in the seven major markets is forecasted to total 225,174 in 2008. While treatment with bisphosphonates reduces the risk of skeletal complications, they do not improve survival in the majority of patients.
Scope
* ...